| |SEPTEMBER 2026709TOP STORIES101115 Pharma Marketing KPIs Indian Companies Should Track in 202612THOUGHT CENTRALHow Deviation Trends Can Reveal Hidden Pharma Quality RisksJayakumar A V, President (Quality), Ajanta Pharma143222423628The Future of Green Chemistry in API ProductionIndia's Path to Billion-Dollar Drugs: Building a Strong EcosystemAI-Augmented Clinical Trials & Drug Development Evolution in IndiaWhy Peptides and Complex Generics Will Define India Pharma's FutureTransforming API & Pharma Manufacturing with Next-Gen EHS TechnologiesAshok Kumar, President, Centre for Research and Development, Ipca LaboratoriesRehan Khan, Managing Director, MSD IndiaJennifer Li, SVP & Head of Sales - APAC, MedidataSaurabh Agarwal, Director, HAB Pharmaceuticals and Research Pharmaceuticals & BiotechDr Kuber Jagdale, President - API Business Unit, Emcure Pharmaceutical Business FormationVIVID OUTLOOKANALYSIS
< Page 6 | Page 8 >